Chlamydia pneumoniae antibodies are associated with an atherogenic lipid profile.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 10026343.
- Also identified by PMC identifier 1728950.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To determine, within a representative population group of men and women, whether alteration of the lipid profile might underlie the reported association between Chlamydia pneumoniae and ischaemic heart disease. Cross sectional survey in an area with a high incidence of ischaemic heart disease. 400 randomly selected participants in the World Health Organisation MONICA project's third population survey in Northern Ireland. Stored sera were examined by microimmunofluorescence for IgG antibodies to C pneumoniae at a dilution of 1 in 64. Mean total and high density lipoprotein (HDL) cholesterol were compared between seropositive and seronegative individuals with adjustment for age, measures of socioeconomic status, smoking habit, alcohol consumption, body mass index, and the season during which blood had been taken. In seropositive men, adjusted mean serum total cholesterol and HDL cholesterol were 0.5 mmol/l (9.2%) higher and 0.11 mmol/l (9.3%) lower, respectively, than in seronegative men. Differences in women did not achieve statistical significance, but both total cholesterol and HDL cholesterol were higher (3.6% and 5.8%, respectively) in seropositive than in seronegative individuals. There is serological evidence that C pneumoniae infection is associated with an atherogenic lipid profile in men. Altered lipid levels may underlie the association between C pneumoniae and ischaemic heart disease.
Medical subject headings
- Antibodies, Bacterial
- Chlamydophila pneumoniae
- Immunoglobulin G
- Lipids
- Myocardial Ischemia